Sign In
Buy OPGN
$24.75
+0 (+0%)
At Close: Jun 02, 2026
OpGen, Inc. (OTC: OPGN) Announces Name Change to CapForce Inc.
05:30pm, Friday, 27'th Feb 2026
CLARKSBURG, Md., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OpGen, Inc. (OTC: OPGN) today announced that it is changing its name to CapForce Inc., effective today. OpGen changed its name to CapForce Inc. in or
OPGN Stock Earnings: OpGen Reported Results for Q2 2024
12:52pm, Wednesday, 21'st Aug 2024
OpGen (NASDAQ: OPGN ) just reported results for the second quarter of 2024. OpGen reported earnings per share of -$1.18.
OPGN Stock Earnings: OpGen Meets Revenue for Q4 2023
09:53am, Wednesday, 05'th Jun 2024
OpGen (NASDAQ: OPGN ) just reported results for the fourth quarter of 2023. OpGen reported earnings per share of -$17.67.
OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
04:05pm, Friday, 24'th May 2024
ROCKVILLE, Md., May 24, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”)
OpGen Announced 1-for-10 Reverse Stock Split
07:00am, Thursday, 16'th May 2024
ROCKVILLE, Md., May 16, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) today announced that the Company's board of directors has approved a 1-for-10 reverse stoc
OpGen Provides Update on Business Operations and Strategic Opportunities
04:05pm, Monday, 29'th Apr 2024
ROCKVILLE, Md., April 29, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it entered into an agreement to sell its commercial customer contra
OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
04:15pm, Tuesday, 23'rd Apr 2024
ROCKVILLE, Md., April 23, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”
OpGen Announces Acquisition of Preferred Stock by David Lazar
04:05pm, Monday, 25'th Mar 2024
ROCKVILLE, Md., March 25, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), announced today that the Company entered into a securities purchase agreement with Davi
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
04:30pm, Tuesday, 14'th Nov 2023
ROCKVILLE, Md., Nov. 14, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinform
OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds
12:32pm, Thursday, 12'th Oct 2023
ROCKVILLE, Md., Oct. 12, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and informat
Why Is OpGen (OPGN) Stock Up 540% Today?
07:57am, Thursday, 12'th Oct 2023
OpGen (NASDAQ: OPGN ) stock is undergoing a massive rally on Thursday following a couple of pieces of news from the precision medicine company. The first bit of news worth mentioning is a progress up
Why Is OpGen (OPGN) Stock Up 115% Today?
08:22am, Friday, 29'th Sep 2023
OpGen (NASDAQ: OPGN ) stock is on the rise Friday after the precision medicine company withdrew a share offering. A filing with the Securities and Exchange Commission (SEC) has the company requesting
OpGen, Inc. (OPGN) Q2 2023 Earnings Call Transcript
07:17pm, Thursday, 10'th Aug 2023
OpGen, Inc. (NASDAQ:OPGN ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Oliver Schacht - President and CEO Albert Weber - Chief Financial Officer Conference Call Pa
OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
04:15pm, Thursday, 10'th Aug 2023
ROCKVILLE, Md., Aug. 10, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinform
OpGen's Subsidiary Ares Genetics Releases New Features to its AREScloud Offering
07:30am, Monday, 07'th Aug 2023
ROCKVILLE, Md., Aug. 07, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat inf
